Acetazolamide
RDCRN 5305
Phase 1 small_molecule terminated
Quick answer
Acetazolamide for Andersen-Tawil Syndrome is a Phase 1 program (small_molecule) at Ultragenyx Pharmaceutical with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ultragenyx Pharmaceutical
- Indication
- Andersen-Tawil Syndrome
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated